Stocks in Focus: STKO, FRCN, AEGY, TFER, AMBS

Pompano Beach, FL -- (SBWIRE) -- 10/31/2012 -- Stakool Inc (OTC:STKO) is currently trading at $0.0003 on a traded volume of 2.78 million shares.So far this year, the stock is down over 99%. The 52-week range for the stock is $0.0 and $0.22.Stakool Incis a development stage company. The Company wasincorporated in 1993.The Company conducts its business operations through ECRV Hanover LeaseCo LLC, ECRV Clinton LeaseCo LLC and ECRV FM LeaseCo LCC.

Will STKO Continue to Jump? Get Our Special Report To Get complete technical analysis on STKO go click my link

Firemans Contractors Inc (OTC:FRCN)is currently trading at $0.0012 on a traded volume of 3.58 million shares.The Company announced the signing of significant parking maintenance contracts with a company that has led the industry nationally in the acquisition of parking facilities over the last five years. The major new client also manages more than $2 billion worth of parking garages, lots, and meters for businesses, airports, hotels, college and university campuses and government and municipal agencies.

To Get complete technical analysis on FRCN go click my link

Alternative Energy Partners Inc (OTC:AEGY) declined 25.0% to $0.0003 on a traded volume of 2.33 million shares.Alternative Energy Partners Inchas entered into an agreement to acquire Safford Acquisition I Corp, which has contracted to acquire a mineral lease on 160 acres of land in Safford AZ.The Company intends to develop, mine and extract gold and other precious metals identified on the site, and then refine and sell the resulting metals.

Get Free Trend Analysis on AEGY go click my link

Titan Iron Ore Corp (OTC:TFER) moved down 12.63% to $0.629. The Company has entered into an agreement with an accredited investor to secure equity line financing. The Company also received funding from convertible debentures.

To Get complete technical analysis on TFER go click my link

AMARANTUS BIOSCI INC (OTC:AMBS) surged up 2.94% to $0.0070 on a traded volume of 1.76 million shares.The Company has received positive behavioural efficacy data for MANF in a neurorestoration 6-hydroxydopamine rat model of Parkinson's disease. The data shows superiority of MANF over GDNF. The Company is a biotechnology company developing new disease-modifying treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centred on its proprietary anti-apoptosis therapeutic protein MANF.

Get Free Trend Analysis on AMBS go click my link

About Csrnewsdaily.com
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.

Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.

Disclaimer
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:
Csrnewsdaily.com
info@csrnewsdaily.com